Multicenter Trial of a Tubeless, On-Body Automated Insulin Delivery System With Customizable Glycemic Targets in Pediatric and Adult Participants With Type 1 Diabetes

OBJECTIVE: Advances in diabetes technology have transformed the treatment paradigm for type 1 diabetes, yet the burden of disease is significant. We report on a pivotal safety study of the first tubeless, on-body automated insulin delivery system with customizable glycemic targets. RESEARCH DESIGN A...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Diabetes Care
Autori principali: Brown, Sue A., Forlenza, Gregory P., Bode, Bruce W., Pinsker, Jordan E., Levy, Carol J., Criego, Amy B., Hansen, David W., Hirsch, Irl B., Carlson, Anders L., Bergenstal, Richard M., Sherr, Jennifer L., Mehta, Sanjeev N., Laffel, Lori M., Shah, Viral N., Bhargava, Anuj, Weinstock, Ruth S., MacLeish, Sarah A., DeSalvo, Daniel J., Jones, Thomas C., Aleppo, Grazia, Buckingham, Bruce A., Ly, Trang T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Diabetes Association 2021
Soggetti:
Emerging Technologies: Data Systems and Devices
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8323171/
https://ncbi.nlm.nih.gov/pubmed/34099518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc21-0172
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi